Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: Smith & Nephew completes first CORI platform clinical cases

8th Jun 2026 21:22

Smith & Nephew PLC - Watford, England-based medical devices maker - Announces the completion of the first clinical cases performed using the next generation CORI XT Handheld Robotics Platform. Calls this an "important milestone" in the clinical introduction of its latest handheld robotics technology.

The CORI platform is designed to be the single handheld robotics platform for all orthopaedic needs - partial to revision knee, hip, and anatomic and reverse shoulders. The first shoulder arthroplasty cases using the platform were performed at Duke Health by a surgical team led by Christopher Klifto. Klifto says: "The CORI shoulder workflow was streamlined and efficient; registration and planning were seamless; and the post op x-rays matched our pre-op planning." Mayank Shandil, Smith & Nephew senior vice president, Global Marketing Orthopaedics and Robotics says: "These first clinical cases reflect close collaboration with surgeon partners and our commitment to introducing handheld robotics in a thoughtful and practical way."

Current stock price: 1,139.00 pence

12-month change: up 2.8%

By Jeremy Cutler, Alliance News reporter

Comments and questions to [email protected]

Copyright 2026 Alliance News Ltd. All Rights Reserved.


Related Shares:

Smith & Nephew
FTSE 100 Latest
Value10,373.20
Change5.15